Publicaciones en las que colabora con CARLOS ROMA MATEO (8)

2020

  1. Thioredoxin and glutaredoxin systems as potential targets for the development of new treatments in Friedreich’s ataxia

    Antioxidants, Vol. 9, Núm. 12, pp. 1-25

2019

  1. Epigenetic biomarkers for disease diagnosis

    Prognostic Epigenetics (Elsevier), pp. 21-44

2018

  1. Oxidative stress and the epigenetics of cell senescence: Insights from progeroid syndromes

    Current Pharmaceutical Design, Vol. 24, Núm. 40, pp. 4755-4770

2017

  1. Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory

    Critical Reviews in Clinical Laboratory Sciences, Vol. 54, Núm. 7-8, pp. 529-550

2016

  1. Circulating Histones and Nucleosomes as Biomarkers in Sepsis and Septic Shock

    Epigenetic Biomarkers and Diagnostics (Elsevier Inc.), pp. 497-517

  2. Circulating histones and nucleosomes as biomarkers in sepsis and septic shock

    Epigenetic biomarkers and diagnostics (Amsterdam [etc.]: Elsevier, 2016), pp. 498-519

2015

  1. Increased Oxidative Stress and Impaired Antioxidant Response in Lafora Disease

    Molecular Neurobiology, Vol. 51, Núm. 3, pp. 932-946

2013

  1. Lafora disease fibroblasts exemplify the molecular interdependence between thioredoxin 1 and the proteasome in mammalian cells

    Free Radical Biology and Medicine, Vol. 65, pp. 347-359